These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6503348)

  • 61. [New methods of insulin therapy].
    Kerner W
    Internist (Berl); 1987 Apr; 28(4):236-42. PubMed ID: 3298123
    [No Abstract]   [Full Text] [Related]  

  • 62. [Changes in the dietary regimen during treatment of type I diabetes mellitus with continuous insulin infusion. II. Omitting food].
    Svacina S; Masek Z; Páv J; Kábrt J; Hilgertová J
    Cas Lek Cesk; 1991 Feb; 130(7):202-5. PubMed ID: 2013073
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Management of diabetics based on blood sugar levels obtained by home-tested blood samples using filter paper].
    Petrányi G
    Orv Hetil; 1984 Nov; 125(45):2749-51. PubMed ID: 6387591
    [No Abstract]   [Full Text] [Related]  

  • 64. Extracorporeal treatment of diabetes in man.
    Galletti PM; Altman JJ
    Trans Am Soc Artif Intern Organs; 1984; 30():675-7. PubMed ID: 6398556
    [No Abstract]   [Full Text] [Related]  

  • 65. The evaluation of a pocket computer as an aid to insulin dose determination by patients.
    Chanoch LH; Jovanovic L; Peterson CM
    Diabetes Care; 1985; 8(2):172-6. PubMed ID: 3838930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Critical evaluation of concepts of insulin therapy.
    Waldhäusl WK
    Life Support Syst; 1985; 3 Suppl 1():507-18. PubMed ID: 3916616
    [No Abstract]   [Full Text] [Related]  

  • 67. [Use of an artificial beta cell based on telemetry].
    Wilke W; Detschew W; Kasch J; Rebrin K; von Woedtke T; Abel P
    Biomed Tech (Berl); 1990; 35 Suppl 3():228-9. PubMed ID: 2078707
    [No Abstract]   [Full Text] [Related]  

  • 68. Medicine. A pancreas in a box.
    Clery D
    Science; 2014 Jan; 343(6167):133-5. PubMed ID: 24408414
    [No Abstract]   [Full Text] [Related]  

  • 69. [Advantages of pulsatile administration of human insulin on endogenous pancreatic secretion in the normal subject and in type 1 diabetics].
    Paolisso G; Sgambato S; Scheen AJ; Torella R; Lefebvre PJ
    Ann Med Interne (Paris); 1988; 139(2):144-5. PubMed ID: 3293501
    [No Abstract]   [Full Text] [Related]  

  • 70. [Analysis of the daily insulin requirements as determined by a biostator (artificial pancreas) in patients with insulin-dependent diabetes mellitus].
    Djurić DS; Mićić JV; Micić D; Brkić V; Nesović M; Djordjević P; Dragasević M
    Srp Arh Celok Lek; 1983; 111(9-10):1351-60. PubMed ID: 6399414
    [No Abstract]   [Full Text] [Related]  

  • 71. Intravenous insulin infusion system to determine insulin regimen in diabetics.
    Ito M; Sato T; Saito T; Kokubun M; Inoue M; Saito K; Yoshinaga K
    Tohoku J Exp Med; 1988 Jan; 154(1):29-36. PubMed ID: 3284000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Use of the blood glucose-controlled Biostator for intravenous infusion of insulin for optimal insulin therapy (so-called corrective feedback)].
    Sieradzki J; Szurkowska M
    Pol Arch Med Wewn; 1986 Feb; 75(2):127-34. PubMed ID: 3748830
    [No Abstract]   [Full Text] [Related]  

  • 73. [The effect of weather on blood sugar fluctuations in insulin-dependent patients. Medical meteorological observations (author's transl)].
    Jendritzky G; Winkler G
    MMW Munch Med Wochenschr; 1979 Jul; 121(29-30):983-6. PubMed ID: 111113
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Development of an automatic system of insulin infusion controlled by blood sugar, its system for the determination of glucose and control algorithms].
    Clemens AH; Chang PH; Myers RW
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():269-78. PubMed ID: 1011418
    [No Abstract]   [Full Text] [Related]  

  • 75. [Portable insulin infusers].
    Souchon E; Schabanel H
    Soins; 1985 Aug; (459-460):37-40. PubMed ID: 3854532
    [No Abstract]   [Full Text] [Related]  

  • 76. Development of remotely controlled implantable devices for programmed insulin infusion.
    Prestele K; Funke H; Möschl R; Reif E; Franetzki M
    Life Support Syst; 1983; 1(1):23-38. PubMed ID: 6379315
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas.
    Raptis S; Mitrakou A; Hadjidakis D; Diamantopoulos E; Anastasiou C; Fountas A; Müller R
    Acta Diabetol Lat; 1987; 24(3):181-92. PubMed ID: 3687311
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of diabetics with the use of a microprocessor: comparison of insulin treatments based on blood and urine glucose levels.
    Hermányi I; Tamás G
    Acta Diabetol Lat; 1988; 25(1):33-40. PubMed ID: 3043988
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Simplified evaluation and documentation of data from glucose controlled insulin infusion systems--artefact handling.
    Peters A; Müller-Esch G; Scriba PC
    Life Support Syst; 1985; 3 Suppl 1():588-92. PubMed ID: 3870620
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insulin delivery systems: do they need a glucose sensor?
    Albisser AM
    Diabetes Care; 1982; 5(3):166-73. PubMed ID: 6756836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.